CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...
Vivera is pleased to announce the launch of LabPort, a comprehensive software solution designed to streamline and integrate the diagnostic testing and results reporting...
Neurolign Technologies™, the global leader in clinical eye-tracking and neuro-functional diagnostic testing, announced the expansion of an ongoing strategic partnership with the Henry M....
